Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Multiple sclerosis (MS) frequently causes cognitive deficits, particularly learning and memory impairments.
• The underlying mechanisms of MS-related cognitive dysfunction are not well understood.
• Hippocampal damage is implicated in cognitive decline in other neurodegenerative diseases.

Purpose of the Study:

• To investigate hippocampal neurodegeneration and inflammation in a mouse model of MS.
• To determine if hippocampal pathology correlates with cognitive deficits in MS.
• To establish a preclinical model for testing therapeutic interventions for MS-induced cognitive dysfunction.

Main Methods:

• Experimental autoimmune encephalomyelitis (EAE) was induced in mice to model MS.
• Histological analysis assessed hippocampal volume, cell death, demyelination, and synaptic markers.
• Behavioral testing evaluated spatial learning and memory performance.

Main Results:

• Early-stage EAE exhibited hippocampal pathology, including reduced CA1 volume, interneuron loss, and increased neuronal/glial cell death.
• Chronic microglial activation was observed with limited blood-borne immune cell infiltration.
• Widespread demyelination occurred, but axonal density remained stable.
• Synaptic proteins and pre-synaptic puncta were significantly reduced, correlating with impaired spatial learning.

Conclusions:

• Neurodegenerative changes and synaptic loss occur in the hippocampus during autoimmune-mediated demyelinating disease (MS model).
• These hippocampal abnormalities are associated with cognitive deficits, specifically spatial learning impairments.
• This EAE model provides a valuable platform for evaluating treatments aimed at preventing MS-related hippocampal neuropathology and cognitive dysfunction.